Yu ZJ - Search Results

1

Alterations in the human oral microbiome in cholangiocarcinoma.

Rao BC, Zhang GZ, Zou YW, Ren T, Ren HY, Liu C, Yu ZJ, Ren ZG. Rao BC, et al. Among authors: yu zj. Mil Med Res. 2022 Nov 8;9(1):62. doi: 10.1186/s40779-022-00423-x. Mil Med Res. 2022. PMID: 36345047 Free PMC article. No abstract available.

2

Coreopsis Tinctoria Modulates Lipid Metabolism by Decreasing Low-Density Lipoprotein and Improving Gut Microbiota.

Ren Z, Li Y, Liu J, Li H, Li A, Hong L, Cui G, Sun R, Wulasihan M, Sun J, Song Y, Yu Z, Chen X. Ren Z, et al. Cell Physiol Biochem. 2018;48(3):1060-1074. doi: 10.1159/000491973. Epub 2018 Jul 24. Cell Physiol Biochem. 2018. PMID: 30041165 Free article.

3

Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma.

Ren Z, Li A, Jiang J, Zhou L, Yu Z, Lu H, Xie H, Chen X, Shao L, Zhang R, Xu S, Zhang H, Cui G, Chen X, Sun R, Wen H, Lerut JP, Kan Q, Li L, Zheng S. Ren Z, et al. Gut. 2019 Jun;68(6):1014-1023. doi: 10.1136/gutjnl-2017-315084. Epub 2018 Jul 25. Gut. 2019. PMID: 30045880 Free PMC article.

4

The successful treatment for cardiac tamponade during radiofrequency ablation of hepatocellular carcinoma.

Xue C, Ren Z, Hu X, He Y, Sun R, Li J, Cui G, Yu Z. Xue C, et al. Hepatobiliary Pancreat Dis Int. 2019 Feb;18(1):90-92. doi: 10.1016/j.hbpd.2018.12.006. Epub 2018 Dec 10. Hepatobiliary Pancreat Dis Int. 2019. PMID: 30579735 No abstract available.

5

miR-450b-5p loss mediated KIF26B activation promoted hepatocellular carcinoma progression by activating PI3K/AKT pathway.

Li H, Shen S, Chen X, Ren Z, Li Z, Yu Z. Li H, et al. Cancer Cell Int. 2019 Jul 31;19:205. doi: 10.1186/s12935-019-0923-x. eCollection 2019. Cancer Cell Int. 2019. PMID: 31388332 Free PMC article.

6

Nanoparticle Conjugation of Ginsenoside Rg3 Inhibits Hepatocellular Carcinoma Development and Metastasis.

Ren Z, Chen X, Hong L, Zhao X, Cui G, Li A, Liu Y, Zhou L, Sun R, Shen S, Li J, Lou J, Zhou H, Wang J, Xu G, Yu Z, Song Y, Chen X. Ren Z, et al. Small. 2020 Jan;16(2):e1905233. doi: 10.1002/smll.201905233. Epub 2019 Dec 9. Small. 2020. PMID: 31814271

7

A Metal-Polyphenol-Coordinated Nanomedicine for Synergistic Cascade Cancer Chemotherapy and Chemodynamic Therapy.

Ren Z, Sun S, Sun R, Cui G, Hong L, Rao B, Li A, Yu Z, Kan Q, Mao Z. Ren Z, et al. Adv Mater. 2020 Feb;32(6):e1906024. doi: 10.1002/adma.201906024. Epub 2019 Dec 13. Adv Mater. 2020. PMID: 31834662

8

Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease.

Wei Z, Ren Z, Hu S, Gao Y, Sun R, Lv S, Yang G, Yu Z, Kan Q. Wei Z, et al. Cancer Med. 2020 Feb;9(3):1254-1262. doi: 10.1002/cam4.2777. Epub 2019 Dec 20. Cancer Med. 2020. PMID: 31860170 Free PMC article.

9

Fecal microbiota transplantation has therapeutic effects on chronic hepatits B patients via altering composition of gut microbiota.

Lou JM, Ren ZG, Li A, Rao BC, Yu ZJ. Lou JM, et al. Among authors: yu zj. Hepatobiliary Pancreat Dis Int. 2020 Oct;19(5):486-487. doi: 10.1016/j.hbpd.2019.12.008. Epub 2020 Jan 10. Hepatobiliary Pancreat Dis Int. 2020. PMID: 31974041 No abstract available.

10

Human microbiome is a diagnostic biomarker in hepatocellular carcinoma.

Rao BC, Lou JM, Wang WJ, Li A, Cui GY, Yu ZJ, Ren ZG. Rao BC, et al. Among authors: yu zj. Hepatobiliary Pancreat Dis Int. 2020 Apr;19(2):109-115. doi: 10.1016/j.hbpd.2020.01.003. Epub 2020 Jan 30. Hepatobiliary Pancreat Dis Int. 2020. PMID: 32037278 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

309 results

Search Page